Brenton R Paolella

Brenton R Paolella

Harvard University

H-index: 18

North America-United States

About Brenton R Paolella

Brenton R Paolella, With an exceptional h-index of 18 and a recent h-index of 16 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Cancer Biology, Genomics, Neurobiology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Therapeutic targeting of phosphate dysregulation in cancer via the xpr1: kidins220 protein complex

Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal

Compositions and methods for treating neoplasia

Rapid prediction of drug responsiveness

Systematic profiling of conditional degron tag technologies for target validation studies

Phosphate dysregulation as a novel therapeutic strategy in ovarian and uterine cancers

Systematic methods to identify cancer vulnerabilities from genome-wide loss-of-function screens: An interactive framework for target discovery

Phosphate dysregulation via the XPR1–KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancer

Brenton R Paolella Information

University

Position

Broad Institute of MIT and Harvard

Citations(all)

3637

Citations(since 2020)

3208

Cited By

1328

hIndex(all)

18

hIndex(since 2020)

16

i10Index(all)

21

i10Index(since 2020)

20

Email

University Profile Page

Google Scholar

Brenton R Paolella Skills & Research Interests

Cancer Biology

Genomics

Neurobiology

Top articles of Brenton R Paolella

Therapeutic targeting of phosphate dysregulation in cancer via the xpr1: kidins220 protein complex

2023/9/7

Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal

Genome Biology

2023/8/23

Compositions and methods for treating neoplasia

2023/6/15

Rapid prediction of drug responsiveness

2022/10/27

Systematic profiling of conditional degron tag technologies for target validation studies

Nature communications

2022/9/20

Systematic methods to identify cancer vulnerabilities from genome-wide loss-of-function screens: An interactive framework for target discovery

Cancer Research

2022/6/15

Phosphate dysregulation via the XPR1–KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancer

Nature cancer

2022/6

Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers

Nature genetics

2021/12

Abstract PR-006: Integrative genomic characterization of therapeutic targets for pancreatic cancer

Cancer Research

2021/11/15

Selective modulation of a pan-essential protein as a therapeutic strategy in cancer

Cancer discovery

2021/9/1

Synthetic lethal interaction between the ESCRT paralog enzymes VPS4A and VPS4B in cancers harboring loss of chromosome 18q or 16q

Cell reports

2021/7/13

Abstract NG01: Synthetic lethal interaction between the ESCRT paralog enzymes VPS4A and VPS4B in cancers harboring loss of chromosome 18q or 16q

Cancer Research

2021/7/1

A first-generation pediatric cancer dependency map

Nature genetics

2021/4

Abstract LB-100: Systematic target prioritization and validation from genome-scale loss-of-function screens in large panels of human cancer cell lines

Cancer Research

2020/8/15

Abstract LB-053: VPS4A is a synthetic lethal target in VPS4B-deficient cancers due to co-deletion with SMAD4

Cancer Research

2020/8/15

Abstract B10: Rhabdomyosarcoma requires MYC family genomic events to pathogenically subvert core-regulatory circuitry

Cancer Research

2020/7/15

Single-gene short-term CRISPR ko viability assay

2020/6/17

In vivo Nanopool: Pooled sgRNA competition assays to evaluate in vivo cancer dependencies

2020/6/17

shRNA Selection and Quality Control for Cancer Target Gene Validation

2020/6/17

See List of Professors in Brenton R Paolella University(Harvard University)